Larvol Delta - AmMax-Bio-Announces-AMB05X-Granted-FDA-Fast-Track-Designation-for-the-Treatment-of-Tenosynovial-Giant-Cell-Tumor-TGCT

AMB-05X - AmMax

https://www.globenewswire.com/news-release/2022/09/07/2511424/0/en/AmMax-Bio-Announces-AMB-05X-Granted-FDA-Fast-Track-Designation-for-the-Treatment-of-Tenosynovial-Giant-Cell-Tumor-TGCT.html

Sep 7, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next